T. Rowe Price Investment Management, Inc. Cv Rx, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Johnson & Johnson New Brunswick, NJ4.1MShares$70.7 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$40.8 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$15.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$14.2 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$11.8 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $355M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...